Litigation Details for SUN PHARMACEUTICAL INDUSTRIES LTD. v. VISTAPHARM, INC. (D.N.J. 2019)
✉ Email this page to a colleague
SUN PHARMACEUTICAL INDUSTRIES LTD. v. VISTAPHARM, INC. (D.N.J. 2019)
| Docket | ⤷ Sign Up | Date Filed | 2019-02-28 |
| Court | District Court, D. New Jersey | Date Terminated | 2019-08-22 |
| Cause | 35:271 Patent Infringement | Assigned To | Stanley R. Chesler |
| Jury Demand | None | Referred To | Cathy L. Waldor |
| Patents | 6,890,957 | ||
| Link to Docket | External link to docket | ||
Small Molecule Drugs cited in SUN PHARMACEUTICAL INDUSTRIES LTD. v. VISTAPHARM, INC.
The small molecule drug covered by the patent cited in this case is ⤷ Sign Up .
Details for SUN PHARMACEUTICAL INDUSTRIES LTD. v. VISTAPHARM, INC. (D.N.J. 2019)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 2019-02-28 | 1 | an action for patent infringement of United States Patent No. 6,890,957 (“the ʼ957 patent”) arising under…Federal Food, Drug, and Cosmetic Act for U.S. Patent No. 6,890,957 (NDA No. N021591)” (“VistaPharm’s Purported… COUNT I FOR INFRINGEMENT OF U.S. PATENT NO. 6,890,957 22. Plaintiffs re-allege and… THE PATENT-IN-SUIT 13. On May 10, 2005, the ʼ957 patent, titled “Liquid Formulation…States Patent and Trademark Office (“USPTO”). Ranbaxy Signature is the sole owner of the ʼ957 patent. | External link to document | |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
